EGFR and neoplasm: However, long-term EGFR-TKI treatment leads to the transformation of tumor immunosurveillance into tumor-promoting inflammation through the induction of Tregs, inhibition of DCs, and the polarization of macrophages toward the M2 phenotype (42, 43).